Results 211 to 220 of about 53,318 (258)

Successful embolisation of a spontaneous diffuse subcapsular liver bleeding in a patient receiving rivaroxaban. [PDF]

CVIR Endovasc
Waters DK, Alderson J, Mulholland D.
europepmc   +1 more source

Rivaroxaban administration after acute ischemic stroke: The RELAXED study

, 2019
Masahiro Yasaka, Kazuo Minematsu, Ḱazunori Toyoda, Etsuro Mori, Teruyuki Hirano, Toshimitsu Hamasaki, Hiroshi Yamagami, Takehiko Nagao, Shinichi Yoshimura, Shinichiro Uchiyama, for the RELAXED study group   +10 more
openalex   +2 more sources

Comparative effectiveness and pharmacological fingerprints of indobufen versus rivaroxaban in patients with chronic kidney disease: a single-center, real-world study. [PDF]

Front Pharmacol
Zhang L, Liu M, Huang T, Zhang H, Huang C, Pan Z, Chen Z, Ning J, Tang J.   +8 more
europepmc   +1 more source

Predictive Role of Metabolic Profiling in Rivaroxaban Efficacy for Thrombus Lysis in Atrial Fibrillation. [PDF]

Int J Mol Sci
Michorowska S, Korytowska-Przybylska N, Piotrowski R, Kułakowski P, Giebułtowicz J.   +4 more
europepmc   +1 more source

Impact of Different DOACs on Complications of TBI After Low-Energy Trauma. [PDF]

J Clin Med
Antoni A, Puhl P, Wedrich L, Wagner R, Millesi M, Weihs V, Schwendenwein E, Aldrian S, Hajdu S.   +8 more
europepmc   +1 more source

RIVAWAR Trial Commentary: Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction. [PDF]

JACC Adv
Abdelnabi M, Almaghraby A, Ibrahim R, Ayoub C, Arsanjani R.   +4 more
europepmc   +1 more source

An ADR pharmaceutical care for severe gastrointestinal bleeding of rivaroxaban in a patient with nonvalvular atrial fibrillation based on TDM and genetic testing: a case report. [PDF]

BMC Med Genomics
Huang Y, Gao H, Chen M, Lin Y, Liu H, Chen M.   +5 more
europepmc   +1 more source

The Use of Estimands in the Design and Analysis of Comparative Effectiveness Trials: The PEPPER Trial. [PDF]

JB JS Open Access
Harri A, Magder LS, Franklin PD, Magaziner JS, Kernan LM, Lambourne CA, Pellegrini VD.   +6 more
europepmc   +1 more source

Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a systematic review of efficacy, safety, and cost-effectiveness. [PDF]

Front Pharmacol
Li B, Zhao L.
europepmc   +1 more source

Association Between History of Rhythm Control Therapy and Clinical Outcomes in Atrial Fibrillation Patients With Stable Coronary Artery Disease: A Sub-Analysis of the AFIRE Trial. [PDF]

J Arrhythm
Wakatsuki D, Suzuki H, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, Yasuda S.   +13 more
europepmc   +1 more source